Abstract:Objective To explore the therapeutic efficacy of a combined treatment modality using transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) to treat hepatocellular carcinoma (HCC) complicated with main branch intraportal vein tumor thrombosis (PVTT).Methods Clinical data was collected retrospectively for patients diagnosed with and treated for HCC plus main branch PVTT at our hospital between January 2007 and January 2010.The total study population (n =51) consisted of 38 males and 13 females,with an average of 50.1 years (range:24-73).Among these patients,26 had been treated with TACE + PEI (group A) and 25 had been treated with TACE alone (group B).Shortterm changes in PvTT (i.e.disappearance,shrinkage,and/or stability) and tumor (i.e.complete response,partial response,and/or stable disease) were assessed by using the t-test (continuous variables) or the Chi-squared or Fisher's exact tests (categorical variables).Between-group differences in survival time were assessed by the Kaplan-Meier analysis and log-rank test.Results The follow-up time ranged from 3-24 months after treatment,and no serious treatment-related complications were recorded for any of the patients (0/51).The time of TACE treatment was significantly longer for the patients receiving the combination therapy (group A:3.21.4 vs.group B:2.40.9,t =2.22,P =0.032).The patients in group A received between 2-8 PEI treatments.The TACE + PEIcombined treatment showed significantly better therapeutic efficacy for PVTT (group A:19/26 vs.group B:10/25,x2 =5.685,P =0.019).The ttmor response was significantly better in patients treated with TACE + PEI at post-treatment month 3 (group A:20/26 vs.group B:18/25,x2 =0.163,P =0.705) and month 6 (group A:17/20 vs.10/19,x2 =2.58,P =0.027).Finally,the average survival time was significantly better in patients treated with TACE + PEI (group A:12.856.02 months (range:5-23) vs.group B:8.653.39 months (range:4-16),t =3.051,P =0.004).Conclusion TACE + PEI combination therapy for main branch PVTT in HCC patients is more efficacious than TACE alone,and is associated with a longer survival time.

Clinical Study of Advanced Primary Hepatocellular Carcinoma Cells after TACE with Use of Portal Vein Perfusion Chemothepary

Evaluation of the Curative Effect of Transcatheter Arterial Chemoembolization Via Hepatic Artery Combined with Percutaneous Ethanol Injection for the Treatment of Primary Hepatocellular Carcinoma

Combined Three Intervened Treatment of TACE,PEI And PVC in Advanced Liver Cancer

Evaluation of the Therapeutic Effect of Hepatic Arterial Chemoembolization Combined with Portal Chemoembolization for Advanced Hepatic Carcinomas

Evaluation of CT-guided ~(125)I Seed Implantation Combined with Transcatheter Arterial Chemoembolization in Treating Portal Vein Tumor Thrombus Associated with Hepatocellular Carcinoma

Clinical Efficacy of Transcatheter Arterial Chemoembolization Combined With Percutaneous Microwave Coagulation Therapy for Advanced Hepatocellular Carcinoma

Clinical Investigation of Chemoembolization of Hepatic Artery Combined with Portal Venous in Treating the Moderate and Advanced Hepatic Carcinomas

Clinical Application of Transarterial Chemoembolization Combining with Air-Cooled Percutaneous Microwave Coagulation Therapy on Patients with Primary Hepatic Carcinoma

[Comparison of Therapeutic Effects Between Transcatheter Arterial Chemoembolization and Transcatheter Arterial-Portal Venous Double Chemoembolization in Treatment of Moderate and Advanced Stages of Primary Liver Carcinoma].

Clinical Efficacy and Safety of transarterial chemoembolization Combined with Targeted Therapy for primary hepatocellular carcinoma

The clinical efficiency of TACE combined with simultaneous computed tomography‐guided radiofrequency ablation for advanced hepatocellular carcinoma

Transarterial Chemoembolization for Hepatocellular Carcinoma Combined with Portal Vein Tumor Thrombosis.

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Prospective Comparative Study

Clinical Study of TACE in Combination with Percutaneous Microwave Coagulation Therapy for Treatment of Hepatocellular Carcinoma

Efficacy of Postoperative Transarterial Chemoembolization and Portal Vein Chemotherapy for Patients with Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis - A Randomized Study

Clinical Investigation of Combined Three Intervened Treatment of TACE.PVC.And PEI in Advanced Hepatic Cancer

Effects of Transcatheter Arterial Chemoembolization in Combination with Portal Vein Chemotherapy on Survival of Patients after Resection of Hepatocellular Carcinoma

Transarterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Prognostic Factors in a Single-Center Study of 188 Patients.

Clinical observation of TACE combined with PEI for unresectable hepatocellular carcinoma

Curative effect of a comprehensive interventional treatment modality on hepatocellular carcinoma complicated with main branch portal vein tumor thrombosis

Therapeutic Effects of Transcatheter Arterial Chemoembolization on Different Types of Tumor Thrombi in Portal Vein in Patients with Hepatocellular Carcinoma